Deltamethrin exposure affects host resistance to Plasmodium infection in mice. Suwanchaichinda C, Khamkong P, Worasuttayangkurn L, Satayavivad J Environ Toxicol Pharmacol 2005; 20: 77-82.

01 Jul 2005
0
0

Deltamethrin exposure affects host resistance to Plasmodium infection in mice.
Suwanchaichinda C, Khamkong P, Worasuttayangkurn L, Satayavivad J
Environ Toxicol Pharmacol 2005; 20: 77-82.

Tags

Share this

Related Posts

Songsiriritthigul, C.; Hanwarinroj, C.; Pakamwong, B.; Srimanote, P.; Suttipanta, N.; Sureram, S.; Suttisintong, K.; Kamsri, P.; Punkvang, A.; Spencer, J.; Kittakoop, P.; Pungpo, P. Inhibition of Mycobacterium tuberculosis InhA by 3-Nitropropanoic Acid. Proteins. 2021, 90, 898-904.
28 Oct 2021
0

Songsiriritthigul, C.; Hanwarinroj, C.; Pakamwong, B.; Srimanote, P.; Suttipanta, N.; Sureram, S.; Suttisintong, K.; Kamsri, P.; Punkvang, A.; Spencer, J.; Kittakoop, P.; Pungpo, P. Inhibition of Mycobacterium tuberculosis InhA by 3-Nitropropanoic Acid. Proteins. 2021, 90, 898-904.

Songsiriritthigul, C.; Hanwarinroj, C.; Pakamwong, B.; Srimanote, P.; Suttipanta, N.; Sureram, S.; Suttisintong, K.; Kamsri, P.; Punkvang, A.; Spencer, J.; Kittakoop, P.; Pungpo, P. Inhibition of Mycobacterium tuberculosis InhA by 3-Nitropropanoic Acid. Proteins. 2021, 90, 898-904.
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
20 Sep 2023
0

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More